ask="11.05"
ask_size="300"
average_daily_volume="203547"
bid="10.55"
bid_size="500"
book_value="3.69"
change="+0.25"
change_from_200_day_moving_average="0.42"
change_from_50_day_moving_average="-1.09"
change_from_52_week_high="-3.75"
change_From_52_week_low="6.97"
change_in_percent="+2.36%"
close="10.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.98"
ex_dividend_date="N/A"
float_shares="15638000"
high="10.95"
high_52_weeks="14.60"
last_trade_date="1/25/2017"
last_trade_price="10.85"
last_trade_size="2825"
last_trade_time="4:00pm"
low="10.50"
low_52_weeks="3.88"
market_capitalization="193.63M"
moving_average_200_day="10.43"
moving_average_50_day="11.94"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="29.25"
open="10.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+4.02%"
percent_change_from_50_day_moving_average="-9.16%"
percent_change_from_52_week_high="-25.68%"
percent_change_from_52_week_low="+179.64%"
previous_close="10.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.87"
price_per_sales="199.63"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.54"
stock_exchange="NCM"
symbol="STML"
volume="202507"
weeks_range_52="3.88 - 14.60"
